On March 30, 2017, Finjan Holdings, Inc. (the Company), Finjan,
Inc. (Finjan), a wholly-owned subsidiary of the Company, and
Finjan Mobile, Inc. (Finjan Mobile), a wholly-owned subsidiary of
the Company, entered into a Confidential Master Agreement (the
Master Agreement) with Sophos Group plc, a public limited company
organized and existing under the laws of England and Wales,
Sophos Limited, a corporation organized and existing under the
laws of England and Wales (Sophos Limited), and Sophos Inc.
(Sophos Inc.), a Massachusetts corporation (collectively,
Sophos). to the Master Agreement, Finjan and Sophos Inc. agreed
to dismiss the suit Finjan, Inc. v. Sophos, Inc. before the
United States District Court of the Northern District of
California (case no. 3:14cv1197-WHO) with prejudice within three
(3) court days after Finjans receipt of the license fee under the
Finjan Inc. License Agreement (defined below). The Master
Agreement also provides for full releases by the parties and
covenants not to sue.

In connection with the Master Agreement, on March 30, 2017,
Finjan entered into a Confidential Patent License Agreement (the
Finjan Inc. License Agreement) with Sophos Limited. to the Finjan
Inc. License Agreement, Sophos Limited and its existing
affiliates will obtain a fully paid up license to the Finjan
patent portfolio and pay a license fee of $15.0 million in cash,
which Finjan received on March 31, 2017.

Finally, in connection with the Master Agreement, on March 30,
2017, Finjan Mobile entered into a Confidential Patent Cross
License Agreement (the Finjan Mobile Cross License Agreement)
with Sophos Limited. to the terms of the Finjan Mobile Cross
License Agreement, the parties will grant patent cross licenses
in the Field of Use (as defined in the Finjan Mobile Cross
License Agreement) and Sophos Limited will pay Finjan Mobile $2.5
million cash, in license fees, as follows: (A) $1.25 million on
or before March 31, 2018, and (B) $1.25 million on or before
March 31, 2019.>>>>

A copy of the press release issued by the Company on April 3,
2017 referencing the above agreements is attached hereto as
Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits